shanahan tdg sig meeting 3 15-11 v2.1
TRANSCRIPT
1
Implementation of Electronic Screening and Clinical Support
into General Outpatient Medicine Practices
Christopher Shanahan MD [email protected]
Boston Medical Center
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 2
Objectives:• Current state: The Informatics of Substance Use
• Experience / Lessons learned from implementing SBIRT in Non-research / Primary Care settings
• Key Issues: Implementing IT innovation in Primary Care Settings
• How can NIDA help General Medical practices implement SBIRT and facilitate development & implementation of Clinical Decision Support?
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 3
Current state: The Informatics of
Substance Use
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 4
• Clinical Core Substance use data-set lacking.• Poor data poor reporting (Garbage in – Garbage out)• Even when accurate, lack of standardized Substance
Use Ontology, makes it difficult or nearly impossible to reliably use that data for clinical use, QI, or research.
• EHR systems generally lack care management / registries for chronic disease management
• Many EHR systems lack real-time, evidence-based clinical decision support
Despite electronic capture of clinical Substance Use data…
because captured data is not standardized, capacity to employ this data continues to lag…
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 5
Experience / Lessons learned from implementing
SBIRT in Non-research / Primary Care settings
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 6
Massachusetts SBIRT (MASBIRT)
• Based on the Health Promotions Advocate (HPA) model• Key Objectives:
1. Universal screening of large numbers of persons
2. Meet SAMHSA data collection/follow-up requirements
To support objectives… Designed & built a web-based, screening & tracking
application optimized to integrated into clinical workflow.
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 7
Typical General Medical Settings are Distinct from Treatment Settings
• Low prevalence: ~80% Negative for harmful EtOH or Substance Use
• Competing Priorities / No time• Little or No Provider/Staff Training• Providers often unwilling to open Pandora’s Box• Little or No Support (SW or Treatment Counselor)• Misaligned Financial Incentives
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 8
• Web-based and device independent (PCs, wireless tablets)
• Centrally located and managed (no data on devices)
• Seamless integration with existing data sources
• Optimized to Point-of-Care workflow
Dynamic work-lists “Hotlist”, Search-n-Screen, Follow-up/Tracking tools
• Flexible, efficient, accurate, and non-obtrusive data collection Point and click application – near zero typing
• Maximal data integrity (build-in rules enforced)
• Master Patient Index eliminated redundant screening
• Real-time management /productivity reporting
• Automated data reporting to SAMHSA
• HIPAA compliant, secure
MASBIRT and IT Infrastructure Designed for General Medical Settings/Primary Care
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 9
The Result• 117,000+ individuals screened over last 4 years at 3
distinct Hospital systems in the Inpatient, Outpatient, Emergency Rooms and 5 FQHCs.
• After Screening scored, risk information/recommendations provided to Primary Care provider via Provider Communication Form (PCF).o Paper given to the PCP, then filed with Medical Records for
scanning to the medical record.o Electronic Document to HERo Direct entry via EHR Form.
• Separate document • Or part of the PCP visit note
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 10
Data Collection & Handling• Providers don’t screen or input resultant data.• Provider Communication Form (PCF) containing
screening results given to Provider during visit.• Tailored recommendations presented with
Screening results (PCF)• PCF data stored in EHR / Viewed by all providers• Documentation from subsequent Brief Intervention
a/o Treatment referral of patients screened (+) stored in protected records
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 11
Observations• Several sites that were not systematically
screening came to understand and embrace Universal Screening and are working to adopt locally with or without HPA model in anticipation of the project end.
• One practice already screening, MASBIRT presence helped enhance performance
(Positivity rates increased from 5% to 25-30%)
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 12
Key Issues: Implementing IT innovation in Primary
Care Settings
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 13
Implementation Lessons• Providers won’t perform screening or input data (so don’t base the
data collection strategy on it.)
• Focus, expertise, standards, & tools not enough, BOTH cultural willingness AND operational capacity required.
“the ground must be fertile”o Do not implement if willingness or capacity are lacking
• Even with willingness and capacity….o Change must ALSO be unobtrusive/fit seamlessly into existing workflow.
• Sustainability “appears” to be generated over time by production feedback & positive results.o Wow!! We have more patients at risk than we ever thought! o This is important and we need to keep doing something about it.o Lets monitor this and make sure we keep doing it well. o Et.al.
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 14
All EHRs are not equal:
Differ in….. • Configurability of Data collection Forms• Capacity to enforce Data Integrity• Capacity to provider alerts• Capacity to provide/configure Clinical Decision Support• Capacity integrate/interoperate/exchange data with other
systems both within and outside of the local health care provider IT infrastructure / network
• Need for modifications to EHR requiring Vendor involvement (may be obstacle).
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 15
Design & Development
Must not substantially increase work
Less is more
Standards improve usability / decrease training
Form improves function • Increased Productivity• Leads to Better Documentation & Data Quality• Leads to Better Decisions• Provides in situ Training
User Interface: Principles for Effectiveness
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 16
How can NIDA help General
Medical practices implement
SBIRT and facilitate development
& implementation of Clinical
Decision Support?
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 17
Baseline Assumptions
• The goal is Screening not Assessment. • Complicated Screening Instruments (i.e. Perfect) are not
acceptable and cannot be used.• Acknowledge that workflow is critical & build tools that
can integrate into it easily.• Operational Workflow (The order of things) &
Information Workflow (What is known by whom & when) are not the same.
Interaction between them is important,
must be understood & developed.
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 18
IT as a Strategy: Cost & Benefits• Costs:
o Substantial Effort: Time, Planning, & Resources.o Long-term strategy: Difficult to sustain given temporal
trends and local shifts in focus.
• Benefits:o Not guaranteed; Dependent on executiono Increasing data granularity enhances utility of
Reporting, QI, Research, & Decision Support .o Unavoidable tradeoffs between efficiency & specificity
Only NIDA’s Leadership will make this possible
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 19
How can NIDA become an Agent of Change and support SBIRT in Practice?
• Support Providers who want to begin SBIRT in their practices need standards based on Best practices & Best Evidence.
• Maximize adoption opportunities by lowering the effort required for change by providing standards and tool sets. o Standard Substance Use Knowledge Set (key data elements
and direct linkage to state-of-the-art screening instruments)o Training & Content tailored for Clinical Decision Support
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 20
Supporting SBIRT in Clinical Practice
Providers need to know…• What to ask (Dataset Standards)
o Establish a Common SBIRT Dataset based on Best Evidence & Practice tailored to Clinical Settings
• How to ask it (Training)o Provide & Communicate accessible Toolkits & Just-in-Time training
at Point of Care (POC) based on Best Evidence & Practiceo EHR based tools must be simultaneously intuitive & educational
• What to do with the answer. (Decision Support)o Develop & provide POC Clinical Decision Support (CDS)
recommendation that can be easily incorporated in to standard electronic Decision support algorithms (e.g. ARDIN)
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 21
Clinical Decision Support (CDS)“System features predict improved clinical practice”
Provided automatically in clinician workflow. p<0.00001
Provided recommendations not only assessments. p=0.02
Provided at decision making at point of care. p=0.03
Computer-based. p=0.03
Kawamoto, et.al.
Nearly all (94%) systems possessing all 4 features significantly improved clinical practice
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 22
Thank you
National Drug Abuse Treatment-CTN / TDG-SIG - 3/15/2011
04/15/2023 23